查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386999

全球转录组学技术市场：趋势、预测与竞争分析（~2030 年）

Transcriptomics Technologies Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

转录组学技术趋势与预测

预计2030年，全球转录组技术市场规模将达到约115亿美元，2024年至2030年复合年增长率为7.8%。该市场的主要驱动力是个人化医疗的日益普及、慢性病盛行率的增加以及转录组学研究和开发的推进。全球转录组学技术市场的未来充满希望，药物研发、诊断和疾病分析市场充满机会。

转录组学技术市场洞察

Lucintel 预计，在预测期内，消耗品仍将占据更大的市场份额。

在这个市场中，由于治疗慢性疾病的新药需求不断增长以及转录组学技术在药物研发发现研究中的应用不断增长，药物研发预计仍将是最大的部分。

由于製药和生技公司研发投资的增加，预计北美在预测期内仍将是最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去五年发生了哪些併购事件，对产业有何影响？

目录

第一章执行摘要

第二章全球转录组技术市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势与预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球转录组学技术市场趋势（2018-2023）与预测（2024-2030）
  • 全球转录组技术市场：按类型
    • 消耗品
    • 装置
    • 软体
    • 服务
  • 全球转录组技术市场：依技术分类
    • 微阵列
    • q PCR
    • 定序技术
  • 全球转录组技术市场：依应用分类
    • 药物研发
    • 诊断/疾病分析
    • 其他的

第四章市场趋势与预测分析：按地区（2018-2030）

  • 全球转录组技术市场：按地区
  • 北美转录组技术市场
  • 欧洲转录组学技术市场
  • 亚太转录组学技术市场
  • 其他地区转录组技术市场

第五章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按类型分類的全球转录组技术市场成长机会
    • 全球转录组技术市场成长机会（按技术）
    • 全球转录组技术市场成长机会（按应用）
    • 按地区分類的全球转录组技术市场成长机会
  • 全球转录组学技术市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球转录组技术市场的产能
    • 全球转录组学技术市场的合併、收购和合资企业

第七章主要企业概况

  • Agilent Technologies
  • Sequentia Biotech SL
  • Affymetrix
  • LC Sciences
  • CD Genomics
  • Thermo Fisher Scientific
  • Life Technologies Corporation
  • GenXPro
  • Merck
  • Bio-Rad Laboratories
简介目录

Transcriptomics Technologies Trends and Forecast

The future of the global transcriptomics technologies market looks promising with opportunities in the drug discovery and diagnostics & disease profiling markets. The global transcriptomics technologies market is expected to reach an estimated $11.5 billion by 2030 with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are growing adoption of personalized medicines, increasing prevalence of chronic disorders, and on-going research and development in transciptomics.

A more than 150-page report is developed to help in your business decisions.

Transcriptomics Technologies by Segment

The study includes a forecast for the global transcriptomics technologies by type, technology, application, and region.

Transcriptomics Technologies Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Consumables
  • Instruments
  • Software
  • Services

Transcriptomics Technologies Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Microarrays
  • q PCR
  • Sequencing Technology

Transcriptomics Technologies Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Drug Discovery
  • Diagnostics & Disease Profiling
  • Others

Transcriptomics Technologies Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Transcriptomics Technologies Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies transcriptomics technologies companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the transcriptomics technologies companies profiled in this report include-

  • Agilent Technologies
  • Sequentia Biotech Sl
  • Affymetrix
  • LC Sciences
  • CD Genomics
  • Thermo Fisher Scientific
  • Life Technologies Corporation
  • Genxpro
  • Merck
  • Bio-Rad Laboratories

Transcriptomics Technologies Market Insights

Lucintel forecasts that consumables will remain the larger segment over the forecast period.

Within this market, drug discovery is expected to remain the largest segment due to growing demand for new drugs to treat chronic diseases and rising application of transcriptomics technologies in drug discovery research.

North America will remain the largest region during the forecast period due to rising R&D investments by pharmaceutical and biotechnology companies in the region.

Features of the Global Transcriptomics Technologies Market

Market Size Estimates: Transcriptomics technologies market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Transcriptomics technologies market size by type, technology, application, and region in terms of value ($B).

Regional Analysis: Transcriptomics technologies market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, technologies, applications, and regions for the transcriptomics technologies market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the transcriptomics technologies market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the transcriptomics technologies market size?

Answer: The global transcriptomics technologies market is expected to reach an estimated $11.5 billion by 2030.

Q.2 What is the growth forecast for transcriptomics technologies market?

Answer: The global transcriptomics technologies market is expected to grow with a CAGR of 7.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the transcriptomics technologies market?

Answer: The major drivers for this market are growing adoption of personalized medicines, increasing prevalence of chronic disorders, and on-going research and development in transciptomics.

Q4. What are the major segments for transcriptomics technologies market?

Answer: The future of the transcriptomics technologies market looks promising with opportunities in the drug discovery and diagnostics & disease profiling markets.

Q5. Who are the key transcriptomics technologies market companies?

Answer: Some of the key transcriptomics technologies companies are as follows:

  • Agilent Technologies
  • Sequentia Biotech Sl
  • Affymetrix
  • LC Sciences
  • CD Genomics
  • Thermo Fisher Scientific
  • Life Technologies Corporation
  • Genxpro
  • Merck
  • Bio-Rad Laboratories

Q6. Which transcriptomics technologies market segment will be the largest in future?

Answer: Lucintel forecasts that consumables will remain the larger segment over the forecast period.

.

Q7. In transcriptomics technologies market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region during the forecast period due to rising R&D investments by pharmaceutical and biotechnology companies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the transcriptomics technologies market by type (consumables, instruments, software, and services), technology (microarrays, q PCR, and sequencing technology), application (drug discovery, diagnostics & disease profiling, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Transcriptomics Technologies Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Transcriptomics Technologies Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Transcriptomics Technologies Market by Type
    • 3.3.1: Consumables
    • 3.3.2: Instruments
    • 3.3.3: Software
    • 3.3.4: Services
  • 3.4: Global Transcriptomics Technologies Market by Technology
    • 3.4.1: Microarrays
    • 3.4.2: q PCR
    • 3.4.3: Sequencing Technology
  • 3.5: Global Transcriptomics Technologies Market by Application
    • 3.5.1: Drug Discovery
    • 3.5.2: Diagnostics & Disease Profiling
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Transcriptomics Technologies Market by Region
  • 4.2: North American Transcriptomics Technologies Market
    • 4.2.2: North American Transcriptomics Technologies Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
  • 4.3: European Transcriptomics Technologies Market
    • 4.3.1: European Transcriptomics Technologies Market by Type: Consumables, Instruments, Software, and Services
    • 4.3.2: European Transcriptomics Technologies Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
  • 4.4: APAC Transcriptomics Technologies Market
    • 4.4.1: APAC Transcriptomics Technologies Market by Type: Consumables, Instruments, Software, and Services
    • 4.4.2: APAC Transcriptomics Technologies Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
  • 4.5: ROW Transcriptomics Technologies Market
    • 4.5.1: ROW Transcriptomics Technologies Market by Type: Consumables, Instruments, Software, and Services
    • 4.5.2: ROW Transcriptomics Technologies Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Transcriptomics Technologies Market by Type
    • 6.1.2: Growth Opportunities for the Global Transcriptomics Technologies Market by Technology
    • 6.1.3: Growth Opportunities for the Global Transcriptomics Technologies Market by Application
    • 6.1.4: Growth Opportunities for the Global Transcriptomics Technologies Market by Region
  • 6.2: Emerging Trends in the Global Transcriptomics Technologies Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Transcriptomics Technologies Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Transcriptomics Technologies Market

7. Company Profiles of Leading Players

  • 7.1: Agilent Technologies
  • 7.2: Sequentia Biotech SL
  • 7.3: Affymetrix
  • 7.4: LC Sciences
  • 7.5: CD Genomics
  • 7.6: Thermo Fisher Scientific
  • 7.7: Life Technologies Corporation
  • 7.8: GenXPro
  • 7.9: Merck
  • 7.10: Bio-Rad Laboratories